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Abstract: Little is known about the impact of depression across a broad range of multimorbid patients
hospitalized for reasons other than depression. The objective of the study was to investigate in a large
sample of multimorbid inpatients whether ancillary depression is associated with increased length of stay
(LOS) and readmissions, two important clinical outcomes with implications for healthcare utilization and
costs. METHODS: We retrospectively analyzed a cohort of 253,009 multimorbid inpatients aged ฀18 at an
academic medical center, 8/2009-8/2017. PRIMARY OUTCOME: LOS. SECONDARY OUTCOMES:
LOS related to different main diagnoses, readmissions within 1, 3, 6, 12, and 24-months after discharge.
RESULTS: Multivariable linear regression showed 24% longer LOS in patients with ancillary depression
(1.24; 95% confidence interval [CI]: 1.22, 1.25). Females stayed 22% longer (1.22; 95% CI: 1.20, 1.25),
males 24% (1.24; 95% CI: 1.22, 1.27). We identified 16 main diagnosis clusters in which ancillary de-
pression was associated with significant LOS increases, with associations being strongest for ”Failure and
rejection of transplanted organs and tissues”, ”Other noninfective gastroenteritis and colitis”, and ”Other
soft tissue disorders, not elsewhere classified”. Multivariable logistic and Poisson regression showed inde-
pendent associations of ancillary depression with increased readmission odds and frequencies at 1, 3, 6,
12, and 24 months. CONCLUSIONS: Ancillary depression was independently associated with increased
LOS and more readmissions across a broad range of multimorbid inpatients.
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Background: Little is known about the impact of depression across a broad range of 
multimorbid patients hospitalized for reasons other than depression. The objective of the 
study was to investigate in a large sample of multimorbid inpatients whether ancillary 
depression is associated with increased length of stay (LOS) and readmissions, two important 
clinical outcomes with implications for healthcare utilization and costs. 
Methods: We retrospectively analyzed a cohort of 253,009 multimorbid inpatients aged ≥18 
at an academic medical center, 8/2009-8/2017. Primary outcome: LOS. Secondary outcomes: 
LOS related to different main diagnoses, readmissions within 1, 3, 6, 12, and 24-months after 
discharge. 
Results: Multivariable linear regression showed 24% longer LOS in patients with ancillary 
depression (1.24; 95% confidence interval [CI]: 1.22, 1.25). Females stayed 22% longer (1.22; 
95% CI: 1.20, 1.25), males 24% (1.24; 95% CI: 1.22, 1.27). We identified 16 main diagnosis 
clusters in which ancillary depression was associated with significant LOS increases, with 
associations being strongest for “Failure and rejection of transplanted organs and tissues”, 
“Other noninfective gastroenteritis and colitis”, and “Other soft tissue disorders, not 
elsewhere classified”. Multivariable logistic and Poisson regression showed independent 
associations of ancillary depression with increased readmission odds and frequencies at 1, 3, 
6, 12, and 24 months. 
Conclusions: Ancillary depression was independently associated with increased LOS and more 




 Depression is one of the largest contributors to global disease burden [1]. Its prevalence 
ranges between 3-10% in the general population, [2,3] 10% in primary care, [4,5] and 10-15% 
in hospitalized patients [6]. Depression often co-occurs with chronic physical diseases [7]. 
There is considerable variation in the rates of comorbid depression in specific diseases, with 
higher rates of prevalence of depression in a range of diseases including cancer (11%), [8] 
Parkinson's disease (17%), [9] acute coronary syndrome (19%), [10] arthritis (10-24%), [11] 
stroke (31%), [12] and diabetes (11-31%) [13].   
The risk for depression is increased among multimorbid patients, [14] and the impact of 
depression on health is most severe when it co-occurs with physical disease [15,16]. Comorbid 
depression is associated with poorer physical functioning and quality of life, [17,18] greater 
disability, [19] and higher rates of mortality, [20,21] compared with those with depression 
only or physical disease only. The relationship between comorbid depression and physical 
disease is considered to be bidirectional, [22] with comorbid depression elevating the risk for 
physical diseases, such as diabetes, [23] stroke [24] and dementia, [25] and physical diseases 
elevating the risk of developing comorbid depression [14]. For example, the likelihood of 
depression increases threefold after a heart attack [26] and the risk of cardio-vascular disease 
increases by up to 90% in patients when there is comorbid depression [27]. 
The overall impact of comorbid depression with physical disease is reflected in higher 
resource utilization and healthcare costs [28]. A number of studies have reported the impact 
of comorbid depression on resource utilization and healthcare costs for specific populations, 
especially in high utilization populations such as diabetes, [29] pain [30] and cancer [31]. 
However, the impact on utilization and costs of comorbid depression as an ancillary condition 
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in multimorbid hospitalized patients with a primary diagnosis other than depression has 
received scant attention [32]. Nevertheless, this is of particular interest in the DRG era, since 
the primary diagnosis is usually the reason for hospital admission and is considered the most 
resource-intensive condition. If ancillary depression is evaluated as the less resource-intensive 
condition, it would be important to ascertain whether it systematically elevates resource 
utilization. Should this be that case, this would give impetus to further studies designed to 
establish the reasons for this and ways to improve patients and hospital outcomes. 
The objective of this study was to investigate among a broad range of multimorbid 
hospitalized patients, whether depression as an ancillary diagnosis is associated with 
increased length of stay (LOS) and readmissions, two important clinical outcomes which also 




Design and study period 
We conducted a retrospective cohort study of all stays of patients discharged from our 
hospital between August 1st, 2009 and August 31st, 2017. Stays of patients who died during 
their stay were not considered. We derived our dataset from electronic health records, that 
is, we used routinely and prospectively collected data. The present investigation used 
completely anonymous data and conformed with the local law as well as the ethical review 
and research policies. Our study adhered to the STrengthening the Reporting of 
OBservational studies in Epidemiology (STROBE) guidelines [34]. 
Setting 
The University Hospital Zurich is a tertiary care academic medical center in Switzerland 
with approximately 850 beds and 35,000 admissions per year. It covers all clinical specialties 
except orthopedic surgery and pediatrics. 
The University Hospital Zurich has a consultation-liaison psychiatric service which is also 
in charge of the center for eating disorders. This center provides 12 beds in proximity to the 
University Hospital Zurich. That setting was not considered as a clinical inpatient unit in the 
present study and these patients were therefore excluded. Thus, a total of 31 clinical units 
cared for the analyzed patients. 
Participants 
We included all multimorbid inpatients aged ≥18. Multimorbidity was defined as the 
presence of two or more diagnoses [35]. Patients with only one diagnosis, patients who 
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were multimorbid due to one main diagnosis plus ancillary depression, and patients with 
depression as their main diagnosis were excluded. Overall, only 9% (n=25,011) of patients 
normally discharged from the considered inpatient units were excluded from our analyses 
(cf. Supplementary Figure SF1). 
Main outcomes and measures 
The primary end point was the impact of ancillary depression on LOS. An additional 
subgroup analysis provided a more detailed examination of this outcome. We stratified the 
subgroup analysis by sex (further data on patient characteristics stratified by sex is 
presented in Supplementary Table ST1 as recommended [36]). Regarding that subgroup 
analysis, we stratified the continuous variable age into five groups. 
Of note, we used the natural logarithm to transform the outcome variable due to the 
skewed distribution of LOS, thereby generating a normal distribution, as described 
elsewhere [37]. This transformation allowed the application of linear regression models to 
investigate the association of ancillary depression with our main outcome. The resulting 
estimated coefficients from the log-transformed outcome were back-transformed by raising 
e to the power of the coefficients. The back-transformed coefficients could then be 
interpreted as percentage increases or decreases (e.g. a back-transformed coefficient 
resulting in a value of 1.24 for ancillary depression would indicate a 24% longer stay). 
Secondary end points included the effect of ancillary depression on LOS in patients 
among main diagnosis groups, and, the association with readmissions within 1 month 
(30 days), 3 months, 6 months, 12 months and 24 months after discharge of the patients. 
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We report main diagnosis groups as ICD-10 categories according to the first three digits 
of the ICD-10 codes (International Classification of Diseases, WHO, Geneva, Switzerland). We 
considered each main diagnosis group if at least 25 stays of patients with ancillary 
depression were in the group (resulting in 135 [11%] groups of a total of 1275 distinct main 
diagnosis groups). Those main diagnosis categories were further analyzed for the secondary 
end point of the effect of ancillary depression on LOS in patients with specific main 
diagnoses. 
The number of patients considered in the readmission analyses varied depending on the 
time frames considered for the following reasons: If a patient was admitted on 3rd of August 
2017, no complete information was available as to whether the patient was readmitted 
within 30 days. Similarly, we were unable to calculate the number of previous admissions in 
the past two years if a patient was admitted in 2010. For the readmission analyses, we 
therefore excluded patients with incomplete data. 
Exposure 
The exposure of interest was depression as an ancillary diagnosis and not as the main 
diagnosis. The first diagnosis in the diagnosis list as defined by the providers was usually the 
main diagnosis, which was additionally flagged as such in the available dataset. 
Depression was defined by the ICD-10 diagnosis codes F20.4, F31.3-F31.5, F32*, F33*, 





Co-variables were included in the regression models according to a priori knowledge and 
literature [39–42]. We controlled for multimorbidity severity by adjusting for diagnosis 
count [43]. 
Multivariable linear regression modelling of the association of ancillary depression with a 
longer LOS adjusted for age, sex, marital status, diagnosis count (excluding depression), year 
discharged, and six chronic diseases (alcohol misuse [44], metastatic cancer [45,46], chronic 
heart failure [47], chronic pain [48], diabetes, [49] all defined by [50], and COPD [51] defined 
by ICD-10 codes J43* or J44*). For the secondary analysis related to LOS, that is depending 
on main diagnoses, the models were adjusted for the same co-variables where appropriate. 
Multivariable logistic regression and Poisson regression modelling of the association of 
ancillary depression with a readmission as a single event, and further with higher numbers of 
readmissions, respectively, were all adjusted for age, sex, marital status, LOS, diagnosis 
count (excluding depression), year discharged, the number of previous stays (past two 
years), and the same six chronic diseases as listed above. 
Statistical analysis 
Descriptive statistics for baseline characteristics included medians and interquartile 
ranges for variables with a non-normal distribution. Numbers and percentages of the total 
were given for categorical variables. We performed comparative statistical analysis to 
describe patients without versus with ancillary depression. We used unpaired Wilcoxon tests 
to compare the distributions of continuous variables between patients without versus with 
ancillary depression, and chi-square tests to compare categorical variables between groups. 
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We considered a p-value of ≤0.05 as indicating statistical significance for the primary end 
point. However, we conservatively controlled for multiple testing in all secondary end point 
analyses by using the Bonferroni correction. For instance, the respective value for the 
analyses of main diagnosis categories had to be ≤0.00037 (0.05/135), since we ran 135 
regression models to test 135 distinct main diagnoses. 
We performed statistical analyses using the software R, version 3.5.0 (R Foundation for 




A total of 278,020 inpatients were normally discharged during the study period. Of those, 
25,011 patients were excluded, leaving 91% of the total number of considered inpatient 
stays for further analysis (Supplementary Figure SF1). The baseline characteristics are 
presented in Table 1. 
Primary end point 
The unadjusted linear regression model resulted in an increased LOS by 56% (1.56; 
95% confidence interval [CI]: 1.53, 1.58) associated with ancillary depression in multimorbid 
hospitalized patients. After adjusting for co-variables, the multivariable linear regression 
model showed that ancillary depression was independently associated with a 24% increase 
of the LOS (Table 2). Of note, each diagnosis in this model resulted in an additional 10% 
increase of the LOS. 
Overall, the adjusted model for the female patients resulted an increase of the LOS by 
22% (1.22; 95% CI: 1.20, 1.25), the model for the males showed an increase by 24% (1.24; 
95% CI: 1.22, 1.27). 
The primary outcome was further examined in a subgroup analysis, stratified by sex 
(Figure 1). The association of ancillary depression with a longer LOS among males with 
other/unknown marital status was statistically insignificant. The only subgroup with a 
potential reduction of LOS associated with ancillary depression was females with alcohol 
misuse, however, that association was statistically insignificant, too. All other subgroups 
showed statistically significant associations of ancillary depression with longer LOS. Ancillary 
depression seemed to increase LOS more among patients aged ≥65 than for the patients 
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aged ≤49. In the subgroup of patients with metastatic cancer, ancillary depression seemed to 
increase LOS the most, for both sexes. 
Secondary end points 
Main diagnoses 
After controlling for multiple testing, 16 main diagnosis categories showed a statistically 
significant association of ancillary depression with increased LOS (Figure 2). 
The top LOS increases were identified for the main diagnosis categories “Failure and 
rejection of transplanted organs and tissues” (ICD-10 code category T86; predominantly 
concerning lung transplants; LOS increased by 121%), “Other noninfective gastroenteritis 
and colitis” (K52; e.g. drug-induced gastroenteritis and colitis; LOS increased by 75%), and 
“Other soft tissue disorders, not elsewhere classified” (M79; e.g. fibromyalgia; LOS increased 
by 69%). 
Readmissions 
After adjusting for co-variables, the logistic regression models showed that ancillary 
depression was independently associated with an increase in the odds of being readmitted 
within 1 month (30 days), 3 months, 6 months, 12 months, and 24 months after discharge. 
Depressed patients were also more frequently readmitted, as demonstrated by adjusted 




The present study shows that ancillary depression is independently associated with 
increased LOS and more frequent readmissions in multimorbid hospitalized patients in which 
a physical disease is the primary diagnosis. These results still apply after controlling for the 
influence of several potentially confounding factors, including demographics and physical 
comorbidities. The findings of this study highlight ancillary depression as an important 
contributory factor in resource utilization among multimorbid hospitalized patients with a 
primary, non-psychiatric diagnosis. 
We investigated a comprehensive range of multimorbid inpatients with a main diagnosis 
other than depression. Our cohort was large and included more than 90% of all inpatients 
normally discharged from our institution over the course of approximately eight years. The 
routinely and prospectively collected electronic health record data enabled us to run adjusted 
regression models comparing depressed patients to those without depression. In an 
innovative analysis, we identified 16 main diagnosis clusters in which ancillary depression was 
associated with particularly substantial LOS increases. 
Similar studies, but with considerably smaller sample sizes, investigated the additive 
effect of psychiatric diseases, including depression, on LOS. They observed increases in LOS 
by 2.6 to 2.8 days [52,53] due to psychiatric diseases. A recent meta-analysis pooled data of 
5,044 inpatients and calculated that depressed patients had an additional LOS of 4.38 days 
[54]. Only two studies that reported a positive relationship between depression and LOS 
used both non-psychiatric diagnoses as index and a similarly broad selection of non-
psychiatric diagnoses [55,56]. In one of these two studies, [55] scores from a self-report 
instrument for depression severity did correlate positively with LOS, but the psychiatric 
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diagnosis for depression did not. In the other study, [56] which is partially comparable to the 
present study, there was a significant effect of “mood disorder” on LOS but of only 0.26 
days. However, it seems the authors did not account for the skewed distribution of LOS. 
In our study, the effect of depression on LOS may have multiple reasons. Generally, 
depression associates with the severity and complexity of disease management of 
concurrent conditions [14,22,57,58]. Patients with comorbid depression have more medical 
symptoms (after controlling for the severity of non-psychiatric conditions) in diseases such 
as diabetes, cardiac disease, and arthritis [59,60]. Somatization makes diagnosis and disease 
management more difficult.  Physical disorders may have a poorer treatment response in 
patients with concurrent depression [61].  Poorer treatment response may be due in part to 
effects of polypharmacy and drug-drug and drug-disease interactions and complications 
[22,62–65]. Symptoms of depression such as loss of interest and energy and poor 
concentration may impact treatment adherence, physical functioning, and recovery during 
the hospital stay [17,18,66]. 
We found only studies with small sample sizes that have investigated the impact of 
depression on readmissions. The finding that a secondary diagnosis of depression is 
associated with more frequent readmissions is consistent with studies for psychiatric 
comorbidity in general [67] and those that specifically examined the role of depression in 
readmissions. One study on 374 patients with congestive heart failure found that depression 
increased the risk for readmission at three and twelve months [68].  Another study on 273 
medical and surgical inpatients report a two-fold increase in days re-hospitalized over four 
years [67].  A further study that included 144 medical patients reported a three-fold increase 
in the likelihood of readmission due to depression [69]. The few studies on elderly patients 
show increase likelihood of readmission due to a history of depression or current depressive 
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symptoms [70,71]. Considered together, our and these findings are consistent in showing 
that depression is a major risk factor for hospital readmission. 
The reasons for depression as a risk factor for hospital readmission are not well studied. 
Depression is associated with poor adherence to medication and behavioural regimens, 
including diet and exercise, which lead to or contribute to readmission [72–75]. One review 
suggests that depression is associated with a lack of social support that might otherwise 
facilitate recovery after discharge, [76,77] reduce stressful events, [78] or increase positive 
symptoms both before or after hospital discharge [76,79]. Pre-existing or post-discharge 
depression may impair recovery of activities of daily living (ADL) function [66,80]. Comorbid 
depression is also associated with complications such as in diabetes or new cardiovascular 
events [63,64]. Somatization and symptom overlap of physical disease and depression may 
render diagnosis and disease management more difficult and enhance likelihood of 
readmission [69,81,82]. 
Limitations 
Limitations of this study should be noted. First, this was a single center study. On the one 
hand, generalizability of results from a single institution is often lower than from multi-
center studies. On the other hand, inclusion of more than 90% of a large inpatient cohort 
over a long time period may enhance generalizability. More specific patient populations are 
referred to our hospital and there is a bias towards multimorbidity and complexity which 
may include psychiatric comorbidity. Also, some of our patients will have been readmitted to 
other institutions. However, readmissions to other hospitals would most likely not have 
biased our conclusions. Second, this was a retrospective analysis of electronic health record 
data. Yet these data were routinely and prospectively collected. In this study, the diagnosis 
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of depression was based on ICD-10 codes that are added to the diagnosis lists by 
professional ICD-10 coding staff after the patients are discharged. This procedure does not 
allow to analyze changes of severity of depression over time during hospital stays. Such an 
analysis may have provided further insights into the relationship between ancillary 
depression and LOS. Third, no prospective screening of depression was performed during 
the study period. In fact, the hospital in which the data were collected does not routinely 
screen for depression. This might explain the low rate of prevalence of depression in our 
dataset (4.9%) compared with a prevalence of 12% averaged across numerous studies on 
hospitalized patients [6]. While our study focused on patients with a recognized diagnosis of 
depression, the low rates of depression suggest that there may be underdiagnosis of 
depression, and it can be assumed that severe cases had been more likely to be diagnosed. 
However, low rates of detection are not unusual in hospitalized patients, [83,84] especially 
in specific disease populations, such as diabetes or cancer [61,85]. Fourth, our models did 
not control for the potential confounders education level, disability measures, and drug 
treatment (e.g. use of antidepressants). Interestingly, a recent study by Angermann et 
al. [86] showed no benefit of escitalopram in terms of mortality, hospitalization, or 
depression improvement among patients with chronic heart failure and depression. 
Implications and conclusions 
The present study suggests important implications on clinical care and resource use: 
Depression may determine worse clinical outcomes among multimorbid inpatients, 
independent of the main diagnosis. According to our results, depression could be considered 
a risk marker that should be more actively detected, diagnosed and coded, whereas its role 
as a modifiable risk factor in subjects with multimorbidity has yet to be investigated. 
Therefore, whether screening for, targeted treatment, and ongoing monitoring of 
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depression in selected inpatient populations may reduce LOS and readmissions should be 
object of further study. 
In conclusion, based on a large cohort with a broad range of multimorbid inpatients, 
ancillary depression was independently associated with longer LOS and readmissions, after 
controlling for potentially confounding factors. This study augments the dearth of 
comparable data on multimorbid patients with concurrent depression and LOS and adds 
support to available studies on readmissions. This study indicates that ancillary depression is 
an important contributory factor in resource utilization among multimorbid inpatients with a 
primary, non-psychiatric diagnosis. Further studies are needed in order to confirm our 
findings, improve our understanding of the relationship between ancillary depression, 
healthcare utilization, and health outcomes, and to identify ways needed to improve 
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Figures and tables 
 
Table 1. The baseline characteristics. 
 
 No depression 
Ancillary diagnosis of 
depression P value Overall 
 (n=240,574) (n=12,435)  (n=253,009) 
Demographics         
Age, median years [IQR] 
57.00 [38.00, 
70.00] 56.00 [44.00, 67.00] 0.07 
57.00 [38.00, 
70.00] 
Female sex, n (%) 121317 (50.4) 6934 (55.8) <0.001 128251 (50.7) 
Marital status, n (%)   <0.001  
   Married/partnered 131953 (54.8) 5573 (44.8)  137526 (54.4) 
   Single 51701 (21.5) 2816 (22.6)  54517 (21.5) 
   Widowed/divorced/separated 50858 (21.1) 3725 (30.0)  54583 (21.6) 
   Other/unknown 6062 (2.5) 321 (2.6)  6383 (2.5) 
Number of diagnoses*, median [IQR] 5.00 [3.00, 8.00] 7.00 [4.00, 11.00] <0.001 5.00 [3.00, 8.00] 
Comorbidities         
Alcohol misuse, n (%) 6514 (2.7) 1053 (8.5) <0.001 7567 (3.0) 
Metastatic cancer, n (%) 17530 (7.3) 1090 (8.8) <0.001 18620 (7.4) 
Chronic heart failure, n (%) 15587 (6.5) 1025 (8.2) <0.001 16612 (6.6) 
Chronic pain, n (%) 8582 (3.6) 1623 (13.1) <0.001 10205 (4.0) 
Diabetes, n (%) 26783 (11.1) 1887 (15.2) <0.001 28670 (11.3) 
COPD, n (%) 9169 (3.8) 804 (6.5) <0.001 9973 (3.9) 
Outcomes         
Length of stay, median days [IQR] 5.00 [3.00, 9.00] 9.00 [4.00, 17.00] <0.001 5.00 [3.00, 9.00] 
Had a 30-day readmission, n (%) 31592 (13.3) 2031 (16.5) <0.001 33623 (13.4) 
 






Table 2. Adjusted multivariable linear regression. Ancillary depression was independently associated with an increased LOS in multimorbid hospitalized 
patients. 
 
Variable Exp(B) (95% CI) 
Ancillary depression 1.24 (1.22,1.25) 
Age, per additional year 1.00 (1.00,1.00) 
Female sex 1.03 (1.03,1.04) 
Marital status     
     Married/partnered ref   
     Single 0.97 (0.96,0.97) 
     Widowed/divorced/separated 0.99 (0.98,0.99) 
     Other/unknown 0.98 (0.96,1.00) 
Number of diagnoses, per additional diagnosis* 1.10 (1.10,1.10) 
Year discharged 0.99 (0.99,0.99) 
Alcohol misuse 0.88 (0.87,0.90) 
Metastatic cancer 1.15 (1.14,1.17) 
Chronic heart failure 0.91 (0.90,0.92) 
Chronic pain 1.23 (1.21,1.24) 
Diabetes 0.86 (0.85,0.87) 
COPD 1.00 (0.99,1.02) 
 





Figure 1. Subgroup analysis of the association of ancillary depression with increased LOS. Each subgroup 
model was adjusted, where appropriate, for age, marital status, diagnosis count (excluding depression), 




Red (dark): female patients. Aquamarine (bright): male patients.  
 






Figure 2. After controlling for multiple testing with the Bonferroni correction, 16 out of 135 main diagnosis categories showed statistically significant 
associations of ancillary depression with increased LOS. In parentheses on the left of the figure are the numbers of not depressed and depressed patients 
shown, respectively. Only main diagnosis categories were considered if at least 25 patients per subgroup had ancillary depression (n=135). Each subgroup 









Table 3. All analyzed time frames showed a statistically significant association of ancillary depression with a readmission event (logistic regression) as well as 
higher frequencies of readmissions (Poisson regression). These associations stayed valid after applying Bonferroni correction. 
 




(% of total study 
population) 
At least 1 
readmission 
(%) 















95% CI  
p 
value  
30-day 191613 (76) 25417 (13) 9985 (5) 1703 (17) 1.13 (1.07,1.20) <0.001 1.12 (1.07,1.18) <0.001 
3-month 185894 (73) 40973 (22) 9689 (5) 2726 (28) 1.12 (1.06,1.17) <0.001 1.14 (1.11,1.18) <0.001 
6-month 177197 (70) 49622 (28) 9215 (5) 3305 (36) 1.15 (1.09,1.21) <0.001 1.16 (1.13,1.20) <0.001 
12-month 159882 (63) 54814 (34) 8262 (5) 3607 (44) 1.18 (1.13,1.25) <0.001 1.19 (1.17,1.22) <0.001 
24-month 126366 (50) 52014 (41) 6364 (5) 3242 (51) 1.19 (1.13,1.26) <0.001 1.21 (1.18,1.24) <0.001 
 
Ancillary depression was independently associated with (i) readmissions and (ii) higher numbers of readmissions. All models adjusted for age, sex, marital 
status, LOS, diagnosis count (excluding depression), year the patient was discharged, number of previous stays (within prior two years), and six chronic 
conditions. Only stays with complete information in respect of prior stays and potential readmission events were considered (depending on analyzed time 
frame). 
 





Supplementary online material 
 
Supplementary Table ST1. The baseline characteristics stratified by sex. 
 
 Females Males P value Overall 
 (n=128,251) (n=124,758)  (n=253,009) 
Depression as ancill ary diagnosis, n (%) 6934 (5.4) 5501 (4.4) <0.001 12435 (4.9) 
Demographics         







Marital status, n (%)   <0.001  
   Married/partnered 66743 (52.0) 70783 (56.7)  137526 (54.4) 
   Single 25988 (20.3) 28529 (22.9)  54517 (21.5) 
   Widowed/divorced/separated 32950 (25.7) 21633 (17.3)  54583 (21.6) 
   Other/unknown 2570 (2.0) 3813 (3.1)  6383 (2.5) 
Number of diagnoses*, median [IQR] 5.00 [3.00, 8.00] 5.00 [3.00, 9.00] <0.001 5.00 [3.00, 8.00] 
Comorbidities         
Alcohol misuse, n (%) 1865 (1.5) 5702 (4.6) <0.001 7567 (3.0) 
Metastatic cancer, n (%) 8095 (6.3) 10525 (8.4) <0.001 18620 (7.4) 
Chronic heart failure, n (%) 5916 (4.6) 10696 (8.6) <0.001 16612 (6.6) 
Chronic pain, n (%) 5752 (4.5) 4453 (3.6) <0.001 10205 (4.0) 
Diabetes, n (%) 9757 (7.6) 18913 (15.2) <0.001 28670 (11.3) 
COPD, n (%) 3270 (2.5) 6703 (5.4) <0.001 9973 (3.9) 
Outcomes         
Length of stay, median days [IQR] 5.00 [3.00, 9.00] 5.00 [3.00, 10.00] 0.179 5.00 [3.00, 9.00] 
Had a 30-day readmission, n (%) 14494 (11.4) 19129 (15.5) <0.001 33623 (13.4) 
 





Supplementary Figure SF1. The study flow diagram. Monomorbid patients and those being multimorbid 
only due to ancillary depression (n=24,839) were excluded. Patients with depression as main diagnosis 
(n=172) were also excluded. 
 
 
 
 
